FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113996929> ?p ?o ?g. }

• W3113996929 endingPage "16" @default.
• W3113996929 startingPage "12" @default.
• W3113996929 abstract "<h2>Abstract</h2><h3>Background</h3> The receptor for advanced glycation end products (RAGE), a transmembrane receptor belonging to the immunoglobulin superfamily, is overexpressed in pulmonary artery smooth muscle cells (PASMCs) in patients with pulmonary arterial hypertension (PAH) and is implicated in the etiology of PAH. Recently, we reported that RAGE-aptamer, a short and single-stranded DNA directed against RAGE, inhibited an inappropriate increase in cultured PASMCs in PAH. The aim of this study was to determine the efficacy of RAGE-aptamer in monocrotaline-induced PAH in rats. <h3>Methods and Results</h3> Rats were assigned to either an untreated control group, a group that received continuous subcutaneous administration of RAGE-aptamer immediately after monocrotaline injection, or a group that received control-aptamer immediately after monocrotaline injection. All rats survived 21 days after injection of monocrotaline and control-aptamer or RAGE-aptamer. Injection of monocrotaline with continuous subcutaneous delivery of control-aptamer resulted in higher right ventricular systolic pressure compared with controls. This increase was attenuated by continuous subcutaneous delivery of RAGE-aptamer. The proportion of small pulmonary arteries with full muscularization was greater in the monocrotaline and control-aptamer group than in the control group. Continuous subcutaneous delivery of RAGE-aptamer significantly reduced the percentage of small pulmonary arteries with full muscularization. <h3>Conclusions</h3> Continuous subcutaneous delivery of RAGE-aptamer suppresses development of monocrotaline-induced PAH in rats. Inhibition of RAGE ameliorates muscularization of small pulmonary arteries. Treatment with RAGE-aptamer might be a new therapeutic option for PAH." @default.
• W3113996929 created "2021-01-05" @default.
• W3113996929 creator A5006691721 @default.
• W3113996929 creator A5017554971 @default.
• W3113996929 creator A5019802899 @default.
• W3113996929 creator A5021973822 @default.
• W3113996929 creator A5029975728 @default.
• W3113996929 creator A5038761025 @default.
• W3113996929 creator A5043888002 @default.
• W3113996929 creator A5044544721 @default.
• W3113996929 creator A5048936597 @default.
• W3113996929 creator A5050052282 @default.
• W3113996929 creator A5058119107 @default.
• W3113996929 creator A5059830493 @default.
• W3113996929 creator A5069940779 @default.
• W3113996929 creator A5072959605 @default.
• W3113996929 creator A5076054524 @default.
• W3113996929 date "2021-07-01" @default.
• W3113996929 modified "2023-10-12" @default.
• W3113996929 title "Inhibitory effects of RAGE-aptamer on development of monocrotaline-induced pulmonary arterial hypertension in rats" @default.
• W3113996929 cites W1503258737 @default.
• W3113996929 cites W1996442754 @default.
• W3113996929 cites W2004567083 @default.
• W3113996929 cites W2008075507 @default.
• W3113996929 cites W2079167630 @default.
• W3113996929 cites W2082570154 @default.
• W3113996929 cites W2097994998 @default.
• W3113996929 cites W2142115399 @default.
• W3113996929 cites W2167319946 @default.
• W3113996929 cites W2318095272 @default.
• W3113996929 cites W2604234545 @default.
• W3113996929 cites W2805842770 @default.
• W3113996929 cites W2806133901 @default.
• W3113996929 cites W2891237404 @default.
• W3113996929 cites W2904180601 @default.
• W3113996929 cites W2946458797 @default.
• W3113996929 cites W2963642983 @default.
• W3113996929 doi "https://doi.org/10.1016/j.jjcc.2020.12.009" @default.
• W3113996929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33386219" @default.
• W3113996929 hasPublicationYear "2021" @default.
• W3113996929 type Work @default.
• W3113996929 sameAs 3113996929 @default.
• W3113996929 citedByCount "5" @default.
• W3113996929 countsByYear W31139969292021 @default.
• W3113996929 countsByYear W31139969292022 @default.
• W3113996929 countsByYear W31139969292023 @default.
• W3113996929 crossrefType "journal-article" @default.
• W3113996929 hasAuthorship W3113996929A5006691721 @default.
• W3113996929 hasAuthorship W3113996929A5017554971 @default.
• W3113996929 hasAuthorship W3113996929A5019802899 @default.
• W3113996929 hasAuthorship W3113996929A5021973822 @default.
• W3113996929 hasAuthorship W3113996929A5029975728 @default.
• W3113996929 hasAuthorship W3113996929A5038761025 @default.
• W3113996929 hasAuthorship W3113996929A5043888002 @default.
• W3113996929 hasAuthorship W3113996929A5044544721 @default.
• W3113996929 hasAuthorship W3113996929A5048936597 @default.
• W3113996929 hasAuthorship W3113996929A5050052282 @default.
• W3113996929 hasAuthorship W3113996929A5058119107 @default.
• W3113996929 hasAuthorship W3113996929A5059830493 @default.
• W3113996929 hasAuthorship W3113996929A5069940779 @default.
• W3113996929 hasAuthorship W3113996929A5072959605 @default.
• W3113996929 hasAuthorship W3113996929A5076054524 @default.
• W3113996929 hasBestOaLocation W31139969291 @default.
• W3113996929 hasConcept C126322002 @default.
• W3113996929 hasConcept C128972844 @default.
• W3113996929 hasConcept C147990577 @default.
• W3113996929 hasConcept C153911025 @default.
• W3113996929 hasConcept C164705383 @default.
• W3113996929 hasConcept C169760540 @default.
• W3113996929 hasConcept C170493617 @default.
• W3113996929 hasConcept C2776390293 @default.
• W3113996929 hasConcept C2778857457 @default.
• W3113996929 hasConcept C2780930700 @default.
• W3113996929 hasConcept C2780940725 @default.
• W3113996929 hasConcept C71924100 @default.
• W3113996929 hasConcept C86803240 @default.
• W3113996929 hasConcept C98274493 @default.
• W3113996929 hasConceptScore W3113996929C126322002 @default.
• W3113996929 hasConceptScore W3113996929C128972844 @default.
• W3113996929 hasConceptScore W3113996929C147990577 @default.
• W3113996929 hasConceptScore W3113996929C153911025 @default.
• W3113996929 hasConceptScore W3113996929C164705383 @default.
• W3113996929 hasConceptScore W3113996929C169760540 @default.
• W3113996929 hasConceptScore W3113996929C170493617 @default.
• W3113996929 hasConceptScore W3113996929C2776390293 @default.
• W3113996929 hasConceptScore W3113996929C2778857457 @default.
• W3113996929 hasConceptScore W3113996929C2780930700 @default.
• W3113996929 hasConceptScore W3113996929C2780940725 @default.
• W3113996929 hasConceptScore W3113996929C71924100 @default.
• W3113996929 hasConceptScore W3113996929C86803240 @default.
• W3113996929 hasConceptScore W3113996929C98274493 @default.
• W3113996929 hasFunder F4320327692 @default.
• W3113996929 hasIssue "1" @default.
• W3113996929 hasLocation W31139969291 @default.
• W3113996929 hasLocation W31139969292 @default.
• W3113996929 hasLocation W31139969293 @default.
• W3113996929 hasOpenAccess W3113996929 @default.
• W3113996929 hasPrimaryLocation W31139969291 @default.

• next